J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

When there is only one pharmacist expected to fill, check the status, and distribute medications to patients at a busy ...

Operator Good morning and thank you all for attending the CVS Health third-quarter 2024 earnings call and webcast. My name is ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This year has been defined by an unsuccessful fight against elevated medical costs for CVS. The third quarter was no ...

Retailers' investments have ranged from strategic pivots for existing clinics to multibillion-dollar acquisitions of primary ...

An Audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS health website at cvshealth where it will be archived for a period of one year. CVS Health ® ...

Eva Marie Uzcategui / Bloomberg / Getty Images CVS Health reported better-than-expected quarterly results, and the new CEO ...

CVS Health Corp (CVS) reports robust growth in retail pharmacy and health services, while navigating challenges in its health ...

CVS Health CEO David Joyner promoted an internal executive, Prem Shah, as company group president and hired from the outside, Steve Nelson, a former UnitedHealthcare CEO.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

CVS Health just rocked the market with a nearly 11% surge in pre-market trading after its Q3 revenue topped expectations, ...